GO:0032217 riboflavin transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032217 (riboflavin transmembrane transporter activity) is a molecular function that enables the transfer of riboflavin (vitamin B2) across biological membranes.
• Riboflavin is converted intracellularly to FMN and FAD, essential cofactors for flavoproteins involved in redox reactions and energy metabolism.
• The bile/arsenite/riboflavin transporter (BART) superfamily includes riboflavin transporters from bacteria to humans.
• In humans, the SLC52 transporter family (SLC52A1, SLC52A2, SLC52A3) mediates riboflavin transport, and mutations in these genes cause riboflavin transporter deficiency.
• Bacterial riboflavin transporters such as RibU from Bacillus subtilis and Corynebacterium glutamicum have been characterized, revealing energy-coupling factor (ECF)-type ABC transporter mechanisms.
• Studying GO:0032217 requires membrane protein expression systems, transport assays, and structural approaches, often complemented by CRISPR-based gene editing to dissect transporter function.
Description
Riboflavin transmembrane transporter activity (GO:0032217) is a molecular function that enables the movement of riboflavin (vitamin B2) from one side of a membrane to the other. Riboflavin is a water-soluble B-complex vitamin that is converted in the cell to flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which are essential cofactors for flavoproteins involved in a wide range of redox reactions and energy metabolism. Because most organisms cannot synthesize riboflavin de novo, they must acquire it from the environment or diet, making specific transport systems critical for cellular function. The bile/arsenite/riboflavin transporter (BART) superfamily encompasses a diverse group of membrane proteins that mediate the transport of riboflavin and related substrates across membranes. In humans, the SLC52 family of transporters (SLC52A1, SLC52A2, SLC52A3) are the primary riboflavin transporters, and their dysfunction is linked to riboflavin transporter deficiency, a rare neurological disorder. In bacteria, riboflavin uptake is mediated by energy-coupling factor (ECF)-type ABC transporters, such as RibU in Bacillus subtilis and Corynebacterium glutamicum, which couple ATP hydrolysis to substrate translocation. Understanding the molecular mechanisms, structural determinants, and regulation of riboflavin transporters is essential for uncovering their roles in health and disease, and for developing therapeutic strategies targeting these pathways.
riboflavin transmembrane transporter activity At A Glance
| GO ID | GO:0032217 |
|---|---|
| GO term | riboflavin transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | riboflavin transporter activity |
| Definition | Enables the transfer of riboflavin from one side of a membrane to the other. Riboflavin (vitamin B2) is a water-soluble B-complex vitamin, converted in the cell to FMN and FAD, cofactors required for the function of flavoproteins. |
| Major function | Transport of riboflavin across biological membranes |
| Related superfamily | Bile/arsenite/riboflavin transporter (BART) superfamily |
| Human genes | SLC52A1, SLC52A2, SLC52A3 |
| Bacterial examples | RibU (Bacillus subtilis, Corynebacterium glutamicum) |
| Transport mechanism | Energy-coupling factor (ECF)-type ABC transporters in prokaryotes |
What Is GO:0032217?
GO:0032217 (riboflavin transmembrane transporter activity) is defined as the molecular function that enables the transfer of riboflavin from one side of a membrane to the other. Riboflavin (vitamin B2) is a water-soluble B-complex vitamin that is converted in the cell to FMN and FAD, cofactors required for the function of flavoproteins. This activity is typically mediated by integral membrane proteins that facilitate the passage of riboflavin across lipid bilayers, often against a concentration gradient using energy from ATP hydrolysis or ion gradients.
Why Is riboflavin transmembrane transporter activity Important in Cell Biology?
Riboflavin transmembrane transporter activity is essential for cellular uptake of vitamin B2, which is a precursor for the coenzymes FMN and FAD that participate in numerous metabolic reactions, including oxidative phosphorylation, fatty acid oxidation, and amino acid metabolism. Defects in riboflavin transport lead to riboflavin deficiency and are associated with human diseases such as riboflavin transporter deficiency, a neurodegenerative disorder characterized by auditory neuropathy, bulbar palsy, and respiratory compromise. In bacteria, riboflavin transporters are critical for virulence and survival, making them potential targets for antimicrobial development. Moreover, understanding the structural and functional properties of these transporters can inform the design of inhibitors or modulators for therapeutic applications.
• Riboflavin is a precursor of FMN and FAD, essential cofactors for flavoproteins involved in redox reactions and energy production.
• Riboflavin transporters are required for cellular uptake of vitamin B2 in organisms that cannot synthesize it.
• Mutations in human SLC52A2 and SLC52A3 cause riboflavin transporter deficiency, a rare neurological disorder.
• Bacterial riboflavin transporters are important for pathogenesis and are potential antibiotic targets.
• The BART superfamily includes transporters for bile acids, arsenite, and riboflavin, highlighting evolutionary links.
• Studying riboflavin transport can reveal mechanisms of membrane protein function and energy coupling.
• Riboflavin transport is relevant to cancer metabolism due to increased demand for flavin cofactors in proliferating cells.
• Understanding transporter structure can aid in drug design for diseases linked to riboflavin deficiency.
• Riboflavin transporters are studied using model organisms such as Saccharomyces cerevisiae and Bacillus subtilis.
• CRISPR-based gene editing enables precise dissection of transporter genes in cellular models.
What Happens During riboflavin transmembrane transporter activity?
Substrate recognition and binding
In simple terms: The transporter first grabs riboflavin from one side of the membrane.
Riboflavin transporters specifically recognize and bind riboflavin with high affinity. In the BART superfamily, conserved residues form a substrate-binding pocket that accommodates the isoalloxazine ring of riboflavin. For example, in the SLC52 family, in silico studies have identified key residues involved in substrate binding and specificity. Bacterial ECF-type transporters such as RibU also exhibit specific binding of riboflavin, which is required for subsequent translocation.
Conformational changes and translocation
In simple terms: The transporter changes shape to move riboflavin across the membrane.
Upon substrate binding, the transporter undergoes conformational changes that allow riboflavin to pass through the membrane. In ECF-type ABC transporters, the substrate-binding component (S component) interacts with the energy-coupling module (EcfA and EcfA' subunits) to facilitate translocation upon ATP hydrolysis. In the BART superfamily, alternating access mechanisms are proposed, where the transporter switches between outward-facing and inward-facing states. Structural studies on related transporters, such as the arsenite permease Acr3, have provided insights into the conformational dynamics of this superfamily.
Energy coupling and driving forces
In simple terms: The transporter uses energy to pump riboflavin into the cell.
Riboflavin transport can be driven by ATP hydrolysis or ion gradients. Prokaryotic ECF-type ABC transporters utilize ATP to energize substrate uptake. In contrast, some eukaryotic transporters may use proton or sodium gradients. For instance, the Saccharomyces cerevisiae Acr3p is an As(III)/H+ antiporter, and its mechanism shares similarities with other BART superfamily members. The energy source determines the directionality and efficiency of riboflavin transport.
Release and intracellular conversion
In simple terms: Once inside, riboflavin is released and converted into active cofactors.
After translocation, riboflavin is released into the cytoplasm, where it is converted to FMN by riboflavin kinase and then to FAD by FAD synthetase. These cofactors are then incorporated into flavoproteins. The transport process is therefore tightly linked to cellular metabolism and flavoprotein function.
Key Genes Involved in GO:0032217 riboflavin transmembrane transporter activity
The following genes and proteins are key players in riboflavin transmembrane transporter activity across different organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC52A1 (RFVT1) | Human riboflavin transporter | Expressed in placenta and small intestine; involved in maternal-fetal riboflavin transfer |
| SLC52A2 (RFVT2) | Human riboflavin transporter | Mutations cause riboflavin transporter deficiency with auditory neuropathy |
| SLC52A3 (RFVT3) | Human riboflavin transporter | Mutations cause Brown-Vialetto-Van Laere syndrome; expressed in testis and small intestine |
| RibU (Bacillus subtilis) | ECF-type riboflavin transporter | Model for studying energy-coupling factor transporters |
| RibU (Corynebacterium glutamicum) | ECF-type riboflavin transporter | Biochemical characterization of riboflavin uptake |
| Acr3 (Saccharomyces cerevisiae) | Arsenite permease, BART superfamily | Structural and functional model for BART transporters |
| BART superfamily members | Diverse transporters for bile/arsenite/riboflavin | Evolutionary and mechanistic studies |
| EcfA/EcfA' (ECF transporters) | ATPase subunits | Energy coupling in prokaryotic vitamin uptake |
| Rnf complex (Clostridium tetanomorphum) | Na+-translocating ferredoxin:NAD+ reductase | Related to energy transduction, not directly riboflavin transport |
| Riboflavin kinase (RFK) | Converts riboflavin to FMN | Downstream metabolic enzyme |
| FAD synthetase (FLAD1) | Converts FMN to FAD | Downstream metabolic enzyme |
| SLC52A1 variants | Riboflavin transport deficiency | Genetic studies in patients |
| SLC52A2 variants | Riboflavin transporter deficiency | Genetic studies in patients |
| SLC52A3 variants | Brown-Vialetto-Van Laere syndrome | Genetic studies in patients |
| RibU homologs | Bacterial riboflavin uptake | Antibiotic target research |
| Acr3p mutants | Arsenite transport | Structure-function studies |
| BART domain proteins | Membrane transport | Comparative genomics |
How Is riboflavin transmembrane transporter activity Regulated?
The regulation of riboflavin transmembrane transporter activity is not fully understood, but some insights exist. In bacteria, the expression of riboflavin transporter genes is often regulated by riboflavin-responsive riboswitches or transcriptional regulators to maintain intracellular flavin homeostasis. In humans, SLC52A2 and SLC52A3 expression can be modulated by riboflavin availability, and post-translational modifications may affect transporter trafficking. However, specific regulatory pathways such as mTOR or ISR have not been directly linked to riboflavin transporters in the provided literature.
riboflavin transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC52A2 | Riboflavin transporter deficiency with auditory neuropathy | Knockout or point-mutation in human neuronal cell lines |
| SLC52A3 | Brown-Vialetto-Van Laere syndrome | Patient-derived iPSCs or CRISPR knock-in of patient mutations |
| SLC52A1 | Riboflavin transport deficiency (rare) | Overexpression and knockout in placental cell models |
| RibU (bacterial) | Bacterial growth and virulence | Bacterial knockout and complementation assays |
| Acr3 (yeast) | Arsenite transport and BART superfamily model | Yeast knockout and point-mutation studies |
Riboflavin transporter deficiency (Brown-Vialetto-Van Laere syndrome)
Mutations in SLC52A2 and SLC52A3 cause riboflavin transporter deficiency, a rare neurological disorder characterized by auditory neuropathy, bulbar palsy, and respiratory compromise. These mutations impair riboflavin transport, leading to reduced intracellular FMN and FAD levels and subsequent flavoprotein dysfunction. High-dose riboflavin supplementation can improve symptoms in some patients, highlighting the importance of the transporter for vitamin B2 homeostasis.
Riboflavin transport and diabetes mellitus
Altered riboflavin metabolism has been observed in diabetes mellitus, and D-ribose metabolic disorder is linked to diabetic complications. Although direct evidence for riboflavin transporter involvement in diabetes is limited, the role of riboflavin in redox balance suggests that transport activity may influence disease progression.
Bacterial infections and antibiotic targeting
Bacterial riboflavin transporters such as RibU are essential for riboflavin uptake and are required for growth and virulence in some pathogens. Therefore, these transporters are potential targets for novel antibiotics. Inhibitors of ECF-type transporters could disrupt bacterial metabolism and provide a new strategy to combat antibiotic-resistant infections.
From riboflavin transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC52A2 impair riboflavin uptake? | CRISPR knockout of SLC52A2 in human cell lines |
| What is the effect of a specific patient mutation on transport activity? | Point mutation knock-in of SLC52A3 variant |
| Can we tag the transporter to study localization? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of SLC52A1 increase riboflavin transport? | Overexpression of SLC52A1 in HEK293 cells |
| Which residues are critical for substrate binding? | Alanine scanning mutagenesis via CRISPR |
| Can we screen for chemical inhibitors of bacterial RibU? | Bacterial knockout and high-throughput screening |
How to Study the riboflavin transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled riboflavin uptake | Transport activity | Kinetic analysis of transporters |
| Cryo-EM | 3D structure | Structural determination of membrane proteins |
| Molecular dynamics simulations | Conformational dynamics | Predicting substrate binding and mutation effects |
| Site-directed mutagenesis | Residue function | Identifying critical residues for transport |
| Gene knockout in bacteria | Growth and riboflavin uptake | Essentiality of transporter genes |
| Fluorescence microscopy | Subcellular localization | Tagged transporter trafficking |
| RNA-seq | Gene expression | Regulation of transporter genes |
| CRISPR screening | Gene function | Identifying novel transport regulators |
Transport assays using radiolabeled riboflavin
Radiolabeled riboflavin uptake assays are a direct method to measure riboflavin transmembrane transporter activity. Cells expressing the transporter of interest are incubated with [3H]-riboflavin, and uptake is quantified by scintillation counting. This method can be used to determine kinetic parameters (Km, Vmax) and to test inhibitors.
Structural biology approaches (cryo-EM, X-ray crystallography)
Structural studies of riboflavin transporters provide insights into substrate binding and transport mechanisms. For example, the structure of the Na+-translocating ferredoxin:NAD+ reductase (Rnf) complex was solved by cryo-EM, offering a template for understanding related membrane complexes. Similar approaches can be applied to riboflavin transporters, although no high-resolution structure of a riboflavin transporter is currently available in the provided literature.
In silico modeling and molecular dynamics
In silico investigations, such as homology modeling and molecular dynamics simulations, have been used to study the structure-function relationship of SLC52 transporters. These methods can predict substrate binding sites, conformational changes, and the impact of disease-associated mutations.
Genetic and biochemical characterization in model organisms
Yeast and bacterial models are valuable for studying riboflavin transport. For instance, Acr3p from Saccharomyces cerevisiae has been characterized using site-directed mutagenesis and transport assays. Similarly, RibU from Bacillus subtilis and Corynebacterium glutamicum has been studied using gene knockouts and complementation.
How CRISPR Can Be Used to Study GO:0032217 riboflavin transmembrane transporter activity
Knockout
CRISPR knockout of riboflavin transporter genes (e.g., SLC52A2, SLC52A3) in human cell lines can abolish riboflavin uptake, leading to reduced intracellular FMN and FAD levels. Such models are useful to study the consequences of transporter loss and to validate the role of specific genes in riboflavin homeostasis.
Point Mutation
CRISPR-mediated point mutations can introduce disease-associated variants (e.g., SLC52A3 mutations found in Brown-Vialetto-Van Laere syndrome) into the endogenous locus. These models allow precise assessment of how specific amino acid changes affect transporter function, trafficking, and substrate affinity.
Knock-in
Knock-in of epitope tags (e.g., FLAG, GFP) or fluorescent proteins at the endogenous riboflavin transporter locus enables real-time imaging and biochemical purification of the transporter. This approach helps to study localization, interaction partners, and dynamics in a physiological context.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of riboflavin transporters can increase transport capacity, which is useful for structural studies, drug screening, and for rescuing transport defects in disease models.
How EDITGENE Supports riboflavin transmembrane transporter activity Research
Researchers studying riboflavin transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in riboflavin uptake, how specific mutations affect transporter function, and what the downstream metabolic consequences are. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions, from gene knockout to precise point mutations and knock-in models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for riboflavin transmembrane transporter activity research.
Frequently Asked Questions About riboflavin transmembrane transporter activity
What is riboflavin transmembrane transporter activity?
It is a molecular function (GO:0032217) that enables the transfer of riboflavin (vitamin B2) across biological membranes, as defined by the Gene Ontology.
What genes are involved in riboflavin transport?
In humans, the SLC52 family genes SLC52A1, SLC52A2, and SLC52A3 encode riboflavin transporters. In bacteria, RibU is a well-characterized riboflavin transporter.
What diseases are associated with defects in riboflavin transporters?
Mutations in SLC52A2 and SLC52A3 cause riboflavin transporter deficiency, also known as Brown-Vialetto-Van Laere syndrome, a neurological disorder.
How is riboflavin transported across membranes?
Riboflavin transporters use conformational changes and energy from ATP hydrolysis or ion gradients to move riboflavin across the membrane.
What is the BART superfamily?
The bile/arsenite/riboflavin transporter (BART) superfamily is a large group of membrane transporters that includes riboflavin transporters from bacteria to humans.
Can CRISPR be used to study riboflavin transporters?
Yes, CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect the function of riboflavin transporter genes in cells.
What are the symptoms of riboflavin transporter deficiency?
Symptoms include auditory neuropathy, bulbar palsy, muscle weakness, and respiratory problems, often presenting in infancy or childhood.
How can I measure riboflavin transport activity?
Radiolabeled riboflavin uptake assays are commonly used to measure transport activity in cells expressing the transporter of interest.
Are there bacterial riboflavin transporters?
Yes, many bacteria use ECF-type ABC transporters such as RibU to take up riboflavin.
What model organisms are used to study riboflavin transport?
Saccharomyces cerevisiae (Acr3) and Bacillus subtilis (RibU) are common models for studying riboflavin transport mechanisms.
Conclusion
Riboflavin transmembrane transporter activity (GO:0032217) is a fundamental molecular function that ensures cellular uptake of vitamin B2, a precursor of essential coenzymes FMN and FAD. Dysregulation of these transporters is linked to human diseases such as riboflavin transporter deficiency, and bacterial transporters are promising antibiotic targets. Advances in structural biology, in silico modeling, and CRISPR-based gene editing are accelerating our understanding of these proteins. EDITGENE's comprehensive CRISPR services can support researchers in dissecting the roles of riboflavin transporters in health and disease.
References
- 1. Mansour NM et al.. 2007. The bile/arsenite/riboflavin transporter (BART) superfamily.. FEBS J 274(3):612-29 PMID: 17288550
- 2. Tai Y et al.. 2024. D-ribose metabolic disorder and diabetes mellitus.. Mol Biol Rep 51(1):220 PMID: 38281218
- 3. Ben Mariem O et al.. 2023. In silico investigation on structure-function relationship of members belonging to the human SLC52 transporter family.. Proteins 91(5):619-633 PMID: 36511838
- 4. Wawrzycka D et al.. 2017. Transmembrane topology of the arsenite permease Acr3 from Saccharomyces cerevisiae.. Biochim Biophys Acta Biomembr 1859(1):117-125 PMID: 27836640
- 5. Vogl C et al.. 2007. Characterization of riboflavin (vitamin B2) transport proteins from Bacillus subtilis and Corynebacterium glutamicum.. J Bacteriol 189(20):7367-75 PMID: 17693491
- 6. Markowska K et al.. 2015. Identification of critical residues for transport activity of Acr3p, the Saccharomyces cerevisiae As(III)/H+ antiporter.. Mol Microbiol 98(1):162-74 PMID: 26123064
- 7. Erkens GB et al.. 2012. Energy coupling factor-type ABC transporters for vitamin uptake in prokaryotes.. Biochemistry 51(22):4390-6 PMID: 22574898
- 8. Vitt S et al.. 2022. Purification and structural characterization of the Na(+)-translocating ferredoxin: NAD(+) reductase (Rnf) complex of Clostridium tetanomorphum.. Nat Commun 13(1):6315 PMID: 36274063
